Seeds of exhaustion: Monsanto is coming to the United States Supreme Court *

USA - October 8 2012
On October 5, the United States Supreme Court agreed to review the case Bowman v. Monsanto Co., Docket No. 11-796 (USSC 2012).

---

Threading the needle between divided infringement issues and patentable subject matter *

USA - June 15 2012
Personalized medicine is an emerging approach to medical practice that carries the promise of effective, individualized treatment.

Co-authors: Michelle Lee,.

---

Life sciences alert: Supreme Court issues groundbreaking decision limiting the types of methods that are eligible for patenting *

USA - March 20 2012
Today, the U.S. Supreme Court handed down a unanimous decision holding that method claims for applying a law of nature using merely conventional steps are not eligible for patent protection.

Co-authors: Robert R. Sachs, Stuart P. Meyer, David Austin, Daniel Brownstone, Pauline Farmer-Koppenol.

---

Justices consider patent process for personalized medicine industry *

USA - February 17 2012
In the past decade, personalized medicine has emerged as one of the most promising areas of medical research.

---

A comparison of US and EU biosimilars regimes *

European Union, USA - January 20 2012
Economic barriers, along with regulatory complexity and uncertainty, are shaping the biosimilars industry into something entirely different from the generic small molecule pharmaceutical industry.

Co-authors: Pauline Farmer-Koppenol.

---